PCM
ZYNE

Portolan Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Portolan Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-434,768
Closed -$1.67M – 149
2020
Q1 		$1.67M Sell
434,768
-1,494
-0.3% -$5.72K 0.25% 95
2019
Q4 		$2.64M Sell
436,262
-341,031
-44% -$2.06M 0.27% 76
2019
Q3 		$5.88M Buy
777,293
+150,557
+24% +$1.14M 0.66% 48
2019
Q2 		$8.49M Buy
+626,736
New +$8.49M 0.91% 44